STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 239.44M | 230.59M | 224.45M | 279.13M | 313.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 239.44M | 230.59M | 224.45M | 279.13M | 313.90M |
| Cost of Revenue | 57.02M | 60.26M | 63.51M | 72.58M | 74.32M |
| Gross Profit | 182.42M | 170.33M | 160.94M | 206.55M | 239.58M |
| SG&A Expenses | 185.78M | 190.10M | 196.43M | 203.82M | 204.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 285.18M | 293.27M | 305.88M | 323.95M | 326.25M |
| Operating Income | -45.74M | -62.68M | -81.43M | -44.81M | -12.35M |
| Income Before Tax | -82.26M | -91.95M | -97.58M | -61.33M | -9.05M |
| Income Tax Expenses | -1.82M | 4.42M | -2.31M | 9.75M | 11.16M |
| Earnings from Continuing Operations | -80.45 | -96.37 | -95.27 | -71.08 | -20.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.45M | -96.37M | -95.27M | -71.08M | -20.21M |
| EBIT | -45.74M | -62.68M | -81.43M | -44.81M | -12.35M |
| EBITDA | -37.42M | -53.99M | -72.99M | -36.82M | -5.46M |
| EPS Basic | -1.63 | -1.95 | -1.93 | -1.44 | -0.41 |
| Normalized Basic EPS | -0.46 | -0.74 | -0.88 | -0.49 | -0.11 |
| EPS Diluted | -1.63 | -1.96 | -1.93 | -1.44 | -0.41 |
| Normalized Diluted EPS | -0.47 | -0.74 | -0.88 | -0.49 | -0.12 |
| Average Basic Shares Outstanding | 198.26M | 197.76M | 197.33M | 196.94M | 196.50M |
| Average Diluted Shares Outstanding | 199.17M | 198.68M | 197.86M | 198.15M | 197.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |